002688 金河生物
已收盘 01-13 15:00:00
资讯
新帖
简况
金河生物：三季度利润下滑因检修及淡季促销
证券之星 · 16:21
金河生物：三季度利润下滑因检修及淡季促销
金河生物（002688）披露子公司获得新兽药注册证书，1月8日股价上涨1.15%
证券之星 · 01-08
金河生物（002688）披露子公司获得新兽药注册证书，1月8日股价上涨1.15%
金河生物：年产3000吨虾青素项目已建成
证券之星 · 01-07
金河生物：年产3000吨虾青素项目已建成
每周股票复盘：金河生物（002688）拟设5000万子公司并回购3万股
证券之星 · 01-03
每周股票复盘：金河生物（002688）拟设5000万子公司并回购3万股
金河生物（002688）披露召开2026年第一次临时股东会通知，12月30日股价下跌0.67%
证券之星 · 2025-12-30
金河生物（002688）披露召开2026年第一次临时股东会通知，12月30日股价下跌0.67%
金河生物（002688）股东内蒙古金河控股有限公司质押1662万股，占总股本2.15%
证券之星 · 2025-12-25
金河生物（002688）股东内蒙古金河控股有限公司质押1662万股，占总股本2.15%
金河生物（002688）披露变更持续督导保荐机构及保荐代表人公告，12月25日股价上涨1.5%
证券之星 · 2025-12-25
金河生物（002688）披露变更持续督导保荐机构及保荐代表人公告，12月25日股价上涨1.5%
股市必读：金河生物（002688）11月6日董秘有最新回复
证券之星 · 2025-11-07
股市必读：金河生物（002688）11月6日董秘有最新回复
金河生物：红法夫酵母虾青素含量按1-1.5%
证券之星 · 2025-11-06
金河生物：红法夫酵母虾青素含量按1-1.5%
金河生物(002688.SZ)：饲料添加剂红法夫酵母获产品批准文号
智通财经 · 2025-11-03
金河生物(002688.SZ)：饲料添加剂红法夫酵母获产品批准文号
金河生物(002688)9月30日股东户数5.05万户，较上期减少21.69%
证券之星 · 2025-10-30
金河生物(002688)9月30日股东户数5.05万户，较上期减少21.69%
图解金河生物三季报：第三季度单季净利润同比下降94.94%
证券之星 · 2025-10-30
图解金河生物三季报：第三季度单季净利润同比下降94.94%
股市必读：金河生物（002688）10月17日董秘有最新回复
证券之星 · 2025-10-20
股市必读：金河生物（002688）10月17日董秘有最新回复
金河生物(002688.SZ)拟简易程序定增募资不超3亿元
智通财经 · 2025-10-14
金河生物(002688.SZ)拟简易程序定增募资不超3亿元
金河生物计划通过A股定向增发筹集最多3亿元，用于项目资金和补充资本
美股速递 · 2025-10-14
金河生物计划通过A股定向增发筹集最多3亿元，用于项目资金和补充资本
金河生物（002688）披露使用部分闲置募集资金暂时补充流动资金，9月19日股价下跌0.72%
证券之星 · 2025-09-19
金河生物（002688）披露使用部分闲置募集资金暂时补充流动资金，9月19日股价下跌0.72%
金河生物收盘上涨2.14%，滚动市盈率37.51倍，总市值55.17亿元
市场资讯 · 2025-09-08
金河生物收盘上涨2.14%，滚动市盈率37.51倍，总市值55.17亿元
金河生物(002688.SZ)控股股东金河控股完成减持 合计减持3%股份
智通财经 · 2025-09-04
金河生物(002688.SZ)控股股东金河控股完成减持 合计减持3%股份
金河生物：虾青素广泛用于水产饲料保健食品及化妆品领域
证券之星 · 2025-09-04
金河生物：虾青素广泛用于水产饲料保健食品及化妆品领域
金河生物：宠物业务板块将作为战略重点有序推进
证券之星 · 2025-09-04
金河生物：宠物业务板块将作为战略重点有序推进
加载更多
公司概况
公司名称：
金河生物科技股份有限公司
所属行业：
医药制造业
上市日期：
2012-07-13
主营业务：
金河生物科技股份有限公司的主营业务是动物保健品的生产、销售、研发及服务。公司的主要产品是兽用化学药品、兽用疫苗、药物饲料添加剂、淀粉及联产品、环保服务、贸易业务。本公司根据科学技术部火炬高技术产业开发中心“关于内蒙古自治区2010年第二,三批高新技术企业备案申请的复函”(国科火字[2011]049号)，同意本公司作为高新技术企业备案，并取得于2010年11月29日颁发的高新技术企业证书。
发行价格：
18.00
{"stockData":{"symbol":"002688","market":"SZ","secType":"STK","nameCN":"金河生物","latestPrice":6.22,"timestamp":1768287801000,"preClose":6.19,"halted":0,"volume":25908755,"delay":0,"changeRate":0.0048,"floatShares":747000000,"shares":772000000,"eps":0.1627,"marketStatus":"已收盘","change":0.03,"latestTime":"01-13 15:00:00","open":6.19,"high":6.29,"low":6.16,"amount":162000000,"amplitude":0.021,"askPrice":6.22,"askSize":1131,"bidPrice":6.21,"bidSize":3226,"shortable":0,"etf":0,"ttmEps":0.1627,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768354200000},"marketStatusCode":5,"adr":0,"adjPreClose":6.19,"symbolType":"stock","openAndCloseTimeList":[[1768267800000,1768275000000],[1768280400000,1768287600000]],"highLimit":6.81,"lowLimit":5.57,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":771634398,"isCdr":false,"pbRate":2.03,"roa":"--","peRate":38.229871,"roe":"6.07%","epsLYR":0.1294,"committee":0.135698,"marketValue":4800000000,"turnoverRate":0.0347,"status":0,"floatMarketCap":4649000000},"requestUrl":"/m/hq/s/002688","defaultTab":"news","newsList":[{"id":"2603509549","title":"金河生物：三季度利润下滑因检修及淡季促销","url":"https://stock-news.laohu8.com/highlight/detail?id=2603509549","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603509549?lang=zh_cn&edition=full","pubTime":"2026-01-13 16:21","pubTimestamp":1768292470,"startTime":"0","endTime":"0","summary":"谢谢金河生物回复：您好，公司第三季度利润下滑主要原因是化药车间安排例行检修、三季度属于行业消费淡季、六期项目投产后产量加大，公司促销优惠等原因所致；公司11月底提高了国内和其他外销市场的金霉素售价，对第四季度的经营业绩或有一定的提升，具体经营情况届时请关注公司披露的相关公告，感谢您对公司的关注！","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300023835.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002688"],"gpt_icon":0},{"id":"2601360191","title":"金河生物（002688）披露子公司获得新兽药注册证书，1月8日股价上涨1.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601360191","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601360191?lang=zh_cn&edition=full","pubTime":"2026-01-08 22:19","pubTimestamp":1767881957,"startTime":"0","endTime":"0","summary":"截至2026年1月8日收盘，金河生物报收于6.14元，较前一交易日上涨1.15%，最新总市值为47.38亿元。该股当日开盘6.06元，最高6.17元，最低6.04元，成交额达8417.82万元，换手率为1.84%。近日，金河生物发布公告称，其子公司杭州佑本、金河佑本、呼市佑本与北京汇康益生联合研发的猪乙型脑炎灭活疫苗获得农业农村部批准，并核发新兽药注册证书。产品在上市前还需申请兽药产品批准文号。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800038915.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002688","BK0239"],"gpt_icon":0},{"id":"2601425998","title":"金河生物：年产3000吨虾青素项目已建成","url":"https://stock-news.laohu8.com/highlight/detail?id=2601425998","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601425998?lang=zh_cn&edition=full","pubTime":"2026-01-07 09:06","pubTimestamp":1767747964,"startTime":"0","endTime":"0","summary":"证券之星消息，金河生物(002688)01月06日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵司生产的虾青素是否已经量产并销售？已经量产上市销售，请问2025年虾青素销售营业额占总营业额的多少？预计2026年能到多少占比？谢谢金河生物回复：您好，公司已建成年产3000吨虾青素项目，相关产品饲料添加剂红法夫酵母已获得产品批准文号，目前正处于市场推广中。具体经营情况届时请关注公司披露的相关公告。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700005339.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002688"],"gpt_icon":0},{"id":"2600060299","title":"每周股票复盘：金河生物（002688）拟设5000万子公司并回购3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2600060299","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600060299?lang=zh_cn&edition=full","pubTime":"2026-01-03 04:02","pubTimestamp":1767384136,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘，金河生物报收于5.95元，较上周的6.05元下跌1.65%。本周，金河生物12月29日盘中最高价报6.06元。本周关注点公司公告汇总：金河生物拟投资5000万元设立全资子公司内蒙古金河东汇生物科技有限公司。股权登记日为2026年1月12日，关联股东需对关联交易议案回避表决。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010300002464.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002688","BK0239"],"gpt_icon":0},{"id":"2595718155","title":"金河生物（002688）披露召开2026年第一次临时股东会通知，12月30日股价下跌0.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595718155","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595718155?lang=zh_cn&edition=full","pubTime":"2025-12-30 22:22","pubTimestamp":1767104541,"startTime":"0","endTime":"0","summary":"公司近日发布公告称，金河生物科技股份有限公司将于2026年1月16日召开2026年第一次临时股东会，会议由董事会召集，现场会议时间为当日14:30，网络投票时间为同日上午9:15至下午15:00。其中部分议案需经出席会议股东所持表决权的三分之二以上通过，关联股东需对关联交易议案回避表决。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123000044227.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002688","BK0239"],"gpt_icon":0},{"id":"2594239660","title":"金河生物（002688）股东内蒙古金河控股有限公司质押1662万股，占总股本2.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594239660","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594239660?lang=zh_cn&edition=full","pubTime":"2025-12-25 18:42","pubTimestamp":1766659332,"startTime":"0","endTime":"0","summary":"证券之星消息，金河生物12月25日公开信息显示，股东内蒙古金河控股有限公司向中信证券股份有限公司合计质押1662.0万股，占总股本2.15%。质押详情见下表：截止本公告日，股东内蒙古金河控股有限公司已累计质押股份9795.0万股，占其持股总数的44.69%。金河生物主营业务：专业从事动物保健品生产、销售、研发及服务,为客户提供一体化动物保健综合产品服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500028473.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002688","BK0239"],"gpt_icon":0},{"id":"2594236558","title":"金河生物（002688）披露变更持续督导保荐机构及保荐代表人公告，12月25日股价上涨1.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594236558","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594236558?lang=zh_cn&edition=full","pubTime":"2025-12-25 17:47","pubTimestamp":1766656048,"startTime":"0","endTime":"0","summary":"截至2025年12月25日收盘，金河生物报收于6.1元，较前一交易日上涨1.5%，最新总市值为47.07亿元。该股当日开盘6.02元，最高6.1元，最低6.01元，成交额达7102.2万元，换手率为1.57%。公司近日发布公告称，因2025年度以简易程序向特定对象发行A股股票，金河生物已与平安证券签署保荐协议，聘请其为本次发行的保荐机构。自协议签署之日起，原保荐机构东方证券未完成的2021年非公开发行股票募集资金持续督导工作由平安证券承接。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500026847.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002688"],"gpt_icon":0},{"id":"2581016754","title":"股市必读：金河生物（002688）11月6日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2581016754","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581016754?lang=zh_cn&edition=full","pubTime":"2025-11-07 02:10","pubTimestamp":1762452630,"startTime":"0","endTime":"0","summary":"截至2025年11月6日收盘，金河生物报收于6.25元，上涨0.0%，换手率1.76%，成交量13.16万手，成交额8198.99万元。董秘最新回复投资者： 请问公司的3000吨虾青素项目的虾青素含量是按照多少比例来计算的？董秘： 您好，目前公司红法夫酵母虾青素含量按1-1.5%，1.5%以上两种规格，依据客户需求生产。当日关注点来自交易信息汇总：11月6日主力资金净流入484.8万元，显示主力对金河生物股票的积极介入。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110700001316.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002688","BK0239"],"gpt_icon":0},{"id":"2581417035","title":"金河生物：红法夫酵母虾青素含量按1-1.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581417035","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581417035?lang=zh_cn&edition=full","pubTime":"2025-11-06 11:36","pubTimestamp":1762400194,"startTime":"0","endTime":"0","summary":"证券之星消息，金河生物(002688)11月06日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司的3000吨虾青素项目的虾青素含量是按照多少比例来计算的？谢谢！！金河生物回复：您好，目前公司红法夫酵母虾青素含量按1-1.5%，1.5%以上两种规格，依据客户需求生产。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110600014143.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002688","BK0239"],"gpt_icon":0},{"id":"2580696261","title":"金河生物(002688.SZ)：饲料添加剂红法夫酵母获产品批准文号","url":"https://stock-news.laohu8.com/highlight/detail?id=2580696261","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580696261?lang=zh_cn&edition=full","pubTime":"2025-11-03 15:47","pubTimestamp":1762156049,"startTime":"0","endTime":"0","summary":"智通财经APP讯，金河生物(002688.SZ)公告，公司收到内蒙古自治区农牧厅核发的《内蒙古自治区农牧厅饲料添加剂产品批准文号审批表》，公司开发的饲料添加剂红法夫酵母获得产品批准文号。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1364407.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"金河生物(002688.SZ)：饲料添加剂红法夫酵母获产品批准文号","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","002688"],"gpt_icon":0},{"id":"2579559113","title":"金河生物(002688)9月30日股东户数5.05万户，较上期减少21.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579559113","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579559113?lang=zh_cn&edition=full","pubTime":"2025-10-30 17:40","pubTimestamp":1761817205,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金河生物披露，截至2025年9月30日公司股东户数为5.05万户，较6月30日减少1.4万户，减幅为21.69%。在动物保健行业个股中，金河生物股东户数高于行业平均水平，截至9月30日，动物保健行业平均股东户数为2.26万户。从股价来看，2025年6月30日至2025年9月30日，金河生物区间涨幅为7.73%，在此期间股东户数减少1.4万户，减幅为21.69%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000033956.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002688","BK0239"],"gpt_icon":0},{"id":"2579187486","title":"图解金河生物三季报：第三季度单季净利润同比下降94.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579187486","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579187486?lang=zh_cn&edition=full","pubTime":"2025-10-30 03:00","pubTimestamp":1761764418,"startTime":"0","endTime":"0","summary":"证券之星消息，金河生物2025年三季报显示，前三季度公司主营收入20.36亿元，同比上升22.86%；归母净利润1.39亿元，同比上升22.25%；扣非净利润1.25亿元，同比上升21.82%；其中2025年第三季度，公司单季度主营收入6.46亿元，同比上升9.2%；单季度归母净利润114.96万元，同比下降94.94%；单季度扣非净利润-324.62万元，同比下降118.45%；负债率53.45%，投资收益-113.91万元，财务费用6747.56万元，毛利率33.83%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000002995.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002688"],"gpt_icon":0},{"id":"2576005335","title":"股市必读：金河生物（002688）10月17日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2576005335","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576005335?lang=zh_cn&edition=full","pubTime":"2025-10-20 04:05","pubTimestamp":1760904311,"startTime":"0","endTime":"0","summary":"截至2025年10月17日收盘，金河生物报收于6.66元，下跌2.06%，换手率1.99%，成交量14.87万手，成交额1.0亿元。董秘最新回复投资者： 公司25年获得的新兽药名称：猪伪狂犬病灭活疫苗，研制单位：浙江大学、杭州佑本动物疫苗有限公司、成都史纪生物制药有限公司。交易信息汇总资金流向10月17日主力资金净流入179.89万元；游资资金净流出893.38万元；散户资金净流入713.49万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102000001443.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002688"],"gpt_icon":0},{"id":"2575293648","title":"金河生物(002688.SZ)拟简易程序定增募资不超3亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2575293648","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575293648?lang=zh_cn&edition=full","pubTime":"2025-10-14 17:45","pubTimestamp":1760435136,"startTime":"0","endTime":"0","summary":"智通财经APP讯，金河生物(002688.SZ)披露2025年度以简易程序向特定对象发行A股股票预案，公司拟向不超过35名(含)特定对象发行股票，发行价格不低于定价基准日前二十个交易日公司股票均价的80%。本次发行的股票数量按照募集资金总额除以发行价格确定，且不超过本次发行前公司总股本的30%。本次发行预计募集资金总额不超过3亿元(含本数)，扣除发行费用后将全部用于污水处理扩容及水资源再生利用提标扩建工程项目、新建产品库房建设项目(粮食储备库)、补充流动资金。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1354863.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","002688"],"gpt_icon":0},{"id":"1144952924","title":"金河生物计划通过A股定向增发筹集最多3亿元，用于项目资金和补充资本","url":"https://stock-news.laohu8.com/highlight/detail?id=1144952924","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144952924?lang=zh_cn&edition=full","pubTime":"2025-10-14 17:24","pubTimestamp":1760433866,"startTime":"0","endTime":"0","summary":"金河生物表示，公司计划通过A股定向增发方式筹集资金，募资规模最高达3亿元人民币，所募集资金将用于项目投资和补充营运资本。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["002688","BK0239"],"gpt_icon":0},{"id":"2568261593","title":"金河生物（002688）披露使用部分闲置募集资金暂时补充流动资金，9月19日股价下跌0.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568261593","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568261593?lang=zh_cn&edition=full","pubTime":"2025-09-19 22:32","pubTimestamp":1758292357,"startTime":"0","endTime":"0","summary":"截至2025年9月19日收盘，金河生物报收于6.89元，较前一交易日下跌0.72%，最新总市值为53.17亿元。该股当日开盘6.92元，最高6.92元，最低6.83元，成交额达9941.46万元，换手率为1.93%。公司近日发布公告称，第六届董事会第三十次会议审议通过《关于使用部分闲置募集资金暂时补充流动资金的议案》，同意使用不超过8,000万元闲置募集资金暂时补充流动资金，使用期限自董事会决议通过之日起不超过12个月。上述事项已获全体董事一致表决通过。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091900037336.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002688","BK0239"],"gpt_icon":0},{"id":"2565950236","title":"金河生物收盘上涨2.14%，滚动市盈率37.51倍，总市值55.17亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2565950236","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565950236?lang=zh_cn&edition=full","pubTime":"2025-09-08 17:08","pubTimestamp":1757322530,"startTime":"0","endTime":"0","summary":"9月8日，金河生物今日收盘7.15元，上涨2.14%，滚动市盈率PE达到37.51倍，总市值55.17亿元。从行业市盈率排名来看，公司所处的农药兽药行业市盈率平均43.26倍，行业中值34.39倍，金河生物排名第32位。截至2025年半年报，共有27家机构持仓金河生物，其中基金25家、QFII1家、其他1家，合计持股数25504.82万股，持股市值15.84亿元。金河生物科技股份有限公司的主营业务是动物保健品的生产、销售、研发及服务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/09/08170852996407.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["002688","BK0239"],"gpt_icon":0},{"id":"2564792683","title":"金河生物(002688.SZ)控股股东金河控股完成减持 合计减持3%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2564792683","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564792683?lang=zh_cn&edition=full","pubTime":"2025-09-04 19:33","pubTimestamp":1756985632,"startTime":"0","endTime":"0","summary":"智通财经APP讯，金河生物(002688.SZ)公告，公司控股股东金河控股股份减持计划已实施完成，其于2025年8月11日至2025年9月1日期间通过大宗交易和集中竞价交易方式共计减持公司股份2256.31万股，占剔除回购股份后公司总股本比例的3%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1341638.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002688","BK0239"],"gpt_icon":0},{"id":"2564321654","title":"金河生物：虾青素广泛用于水产饲料保健食品及化妆品领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2564321654","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564321654?lang=zh_cn&edition=full","pubTime":"2025-09-04 15:42","pubTimestamp":1756971728,"startTime":"0","endTime":"0","summary":"证券之星消息，金河生物(002688)09月04日在投资者关系平台上答复投资者关心的问题。投资者提问：你好 董秘 公司布局的虾青素产品主要用途为饲料添加剂么?市场规模有多大?金河生物回复：您好，虾青素是一种抗氧化剂和着色剂，广泛用于水产、饲料、保健食品及化妆品领域，全球市场规模30-40亿美元。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090400020526.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002688"],"gpt_icon":0},{"id":"2564032163","title":"金河生物：宠物业务板块将作为战略重点有序推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2564032163","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564032163?lang=zh_cn&edition=full","pubTime":"2025-09-04 15:39","pubTimestamp":1756971575,"startTime":"0","endTime":"0","summary":"证券之星消息，金河生物09月04日在投资者关系平台上答复投资者关心的问题。公司宠物板块布局以化药和疫苗产品为主，保健类产品为辅。公司宠物业务板块总体策略为“双品双线”模式，公司在国内、国外分别研发和生产具有优势的化药、制剂、疫苗和保健类产品，国外研发生产的产品后续可由国内公司进行销售，形成进口国产双品牌。宠物业务板块将作为战略重点板块有序推进。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090400020216.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002688","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1768297064096,"stockEarnings":[{"period":"1week","weight":0.0265},{"period":"1month","weight":0.0386},{"period":"3month","weight":-0.1207},{"period":"6month","weight":-0.1029},{"period":"1year","weight":0.5675},{"period":"ytd","weight":0.0403}],"compareEarnings":[{"period":"1week","weight":0.0353},{"period":"1month","weight":0.0709},{"period":"3month","weight":0.0776},{"period":"6month","weight":0.1888},{"period":"1year","weight":0.3146},{"period":"ytd","weight":0.0495}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"金河生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"50527人(较上一季度减少21.69%)","perCapita":"14793股","listingDate":"2012-07-13","address":"内蒙古自治区呼和浩特市托克托县新坪路71号","registeredCapital":"77163万元","survey":" 金河生物科技股份有限公司的主营业务是动物保健品的生产、销售、研发及服务。公司的主要产品是兽用化学药品、兽用疫苗、药物饲料添加剂、淀粉及联产品、环保服务、贸易业务。本公司根据科学技术部火炬高技术产业开发中心“关于内蒙古自治区2010年第二,三批高新技术企业备案申请的复函”(国科火字[2011]049号)，同意本公司作为高新技术企业备案，并取得于2010年11月29日颁发的高新技术企业证书。","listedPrice":18},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"金河生物(002688)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供金河生物(002688)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"金河生物,002688,金河生物股票,金河生物股票老虎,金河生物股票老虎国际,金河生物行情,金河生物股票行情,金河生物股价,金河生物股市,金河生物股票价格,金河生物股票交易,金河生物股票购买,金河生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"金河生物(002688)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供金河生物(002688)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}